Pembrolizumab as Neoadjuvant Therapy Preceding Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Group, Phase 2 Study

Pembrolizumab as Neoadjuvant Therapy Preceding Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Group, Phase 2 Study / Necchi, A., Anichini, A., Raggi, D., Briganti, A., Massa, S., Lucian(\`o), R., Colecchia, M., Giannatempo, P., Mortarini, R., Bianchi, M., Monopoli, F., Colombo, R., Gallina, A., Salonia, A., Messina, A., Ali, S.M., Madison, R., Ross, J.S., Chung, J.H., Salvioni, R., et al.. - In: JOURNAL OF ONCOLOGY. - ISSN 1687-8469. - (2018). [10.2139/ssrn.3225486]